STOCK TITAN
  1. Home
  2. Sec-filings
  3. PRME
  4. [EFFECT] Prime Medicine, Inc. SEC Filing

[EFFECT] Prime Medicine, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 4, 2026
Accession Number: 0001894562-26-000009
Submission Type: POS AM
CIK: 0001894562
Company Name: Prime Medicine, Inc.
File Number: 333-291348

Source: View Original Filing on SEC EDGAR

Prime Medicine

NASDAQ:PRME

View PRME Stock Overview →

PRME Rankings

#3290 Ranked by Market Cap
N/A Ranked by Dividends

PRME Latest News

Mar 3, 2026
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
Feb 25, 2026
Prime Medicine to Participate in Upcoming Investor Conferences
Jan 7, 2026
Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference
Dec 7, 2025
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
Nov 25, 2025
Prime Medicine to Present at 8th Annual Evercore Healthcare Conference

PRME Latest SEC Filings

Mar 3, 2026
[POS AM] Prime Medicine, Inc. SEC Filing
Mar 3, 2026
[10-K] Prime Medicine, Inc. Files Annual Report
Mar 3, 2026
[POSASR] Prime Medicine, Inc. SEC Filing
Mar 3, 2026
[8-K] Prime Medicine, Inc. Reports Material Event
Feb 27, 2026
[Form 4] Prime Medicine, Inc. Insider Trading Activity

PRME Stock Data

599.43M
137.61M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CAMBRIDGE